Medicine:Paris-Trousseau syndrome

From HandWiki
Paris-Trousseau syndrome
Other namesParis-Trousseau thrombocytopenia[1]

Paris-Trousseau syndrome (PTS) is an inherited disorder characterized by mild hemorrhagic tendency associated with 11q chromosome deletion.[2][3] It manifests as a granular defect within an individual's platelets. It is characterized by thrombocytes with defects in α-granule components which affects the cell's surface area and, consequently, its ability to spread when necessary.[citation needed]

FLI1 has been suggested as a candidate.[4]

There is no curative treatment. Management is based on supportive measures to prevent and control bleeding: avoiding drugs that affect platelet function, such as aspirin or NSAIDs, antifibrinolytics (tranexamic acid) for mild bleeding, and platelet transfusion in severe bleeding or before surgery.[5]

See also

References

Classification
External resources